| 阿迪拉·苏力旦,夏依达·乌斯满江,郭颖贞,等.2020年新疆肿瘤登记地区恶性肿瘤发病与死亡特征及2016—2020年变化趋势分析[J].中国肿瘤,2025,34(7):513-521. |
| 2020年新疆肿瘤登记地区恶性肿瘤发病与死亡特征及2016—2020年变化趋势分析 |
| Cancer Incidence and Mortality in Xinjiang Cancer Regi-stration Areas in 2020 and Trends from 2016 to 2020 |
| 投稿时间：2025-01-02 |
| DOI：10.11735/j.issn.1004-0242.2025.07.A003 |
|
 |
| 中文关键词: 恶性肿瘤 发病率 死亡率 变化趋势 新疆 |
| 英文关键词:cancer incidence mortality trends Xinjiang |
| 基金项目:“天山英才”医药卫生高层次人才培养计划（TSYC202301B159） |
|
| 摘要点击次数: 66 |
| 全文下载次数: 25 |
| 中文摘要: |
| 摘 要：［目的］ 分析新疆肿瘤登记地区2020年恶性肿瘤发病与死亡特征以及2016—2020年变化趋势。［方法］ 收集2020年新疆4个肿瘤登记处上报的恶性肿瘤发病与死亡资料，计算恶性肿瘤的发病和死亡粗率、中国人口标化率（中标率）、世界人口标化率（世标率）、0～74岁累积率等指标，中标率和世标率分别采用2000年全国普查标准人口年龄构成和Segi世界标准人口年龄构成为标准进行计算。应用Joinpoint对2016—2020年恶性肿瘤发病和死亡趋势进行分析，计算平均年度变化百分比（average annual percentage change，AAPC）。［结果］ 2020年新疆肿瘤登记地区恶性肿瘤粗发病率为291.67/10万（男性为286.64/10万，女性为296.64/10万），中标发病率为190.43/10万，世标发病率为206.58/10万，0~74岁累积发病率为20.51％。恶性肿瘤粗死亡率为185.58/10万（男性为218.79/10万，女性为152.78/10万），中标率为109.13/10万，世标率为126.64/10万，0~74岁累积死亡率为11.54%。2020年新疆肿瘤登记地区恶性肿瘤发病率和死亡率均随年龄增长呈上升趋势，分别于80~84岁组和85岁及以上组达到峰值。粗发病率排名第1位的恶性肿瘤为肺癌，为51.13/10万，其后依次是女性乳腺癌、甲状腺癌、结直肠癌和胃癌；粗死亡率排名第1位的恶性肿瘤是肺癌，为41.14/10万，其后依次是肝癌、结直肠癌、胃癌和女性乳腺癌。2016—2020年新疆肿瘤登记地区恶性肿瘤的中标发病率和中标死亡率保持稳定（发病AAPC=2.95%，死亡AAPC=8.51%，P均>0.05）。［结论］ 2016—2020年新疆肿瘤登记地区恶性肿瘤发病和死亡情况保持稳定，肺癌、消化系统恶性肿瘤（结直肠癌、胃癌、肝癌）、女性乳腺癌仍是威胁新疆居民健康的主要癌症，提示需进一步强化筛查与早诊早治。 |
| 英文摘要: |
| Abstract：［Purpose］ To analyze cancer incidence and mortality in Xinjiang cancer registration areas in 2020 and the trends from 2016 to 2020. ［Methods］ Incidence and mortality data of cancer reported by four cancer registration areas in Xinjiang in 2020 were collected. Crude incidence and mortality rates， age-standardized incidence and mortality rates by Chinese standard population(ASIRC/ASMRC)， and world standard population(ASIRW， ASMRW)， and cumulative rate (0~74 years old) were calculated. The Chinese standard population (2000 national census) and Segi’s world standard population were used for standardization. Joinpoint regression was applied to analyze the trends of incidence and mortality from 2016 to 2020， and the average annual percentage change (AAPC) was calculated. ［Results］ In 2020， the crude incidence rate of cancer in Xinjiang cancer registration areas was 291.67/105 (286.64/105 for male， 296.64/105 for female)， ASIRC and ASIRW were 190.43/105 and 206.58/105， and the cumulative incidence rate(0～74 years old) was 20.51%. The crude mortality rate was 185.58/105 (218.79/105 for male， 152.78/105 for female)， ASMRC and ASMRW were 109.13/105 and 126.64/105， and the cumulative mortality rate(0~74 years old) was 11.54%. In 2020， the incidence and mortality rates increased with age， peaking in the age groups of 80~84 and ≥85 years old， respectively. Lung cancer was the leading cause of incidence (crude incidence rate： 51.13/105)， followed by female breast cancer， thyroid cancer，colorectal cancer and stomach cancer. Lung cancer was also the leading cause of mortality (crude mortality rate： 41.14/105)， followed by liver cancer， colorectal cancer， stomach cancer and female breast cancer. There was no significant change in the ASIRC/ASMRC from 2016 to 2020(incidence AAPC=2.95%， mortality AAPC=8.51%， both P>0.05). ［Conclusion］ The incidence and mortality of cancer in Xinjiang cancer registration areas were stable from 2016 to 2020. Lung cancer， digestive system cancers (colorectal， gastric， liver cancers)， and female breast cancer remain the main cancers threatening the health of Xinjiang residents， indicating the need to strengthen screening and early diagnosis and treatment. |
|
在线阅读
查看全文 查看/发表评论 下载PDF阅读器 |